Flora Peyvandi: Intrinsic Thrombin Generation in Severe Hemophilia A
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X about a recent article by Emma H. Urlings et al. published in Research and Practice in Thrombosis and Haemostasis, adding:
”Intrinsic Activated Thrombin Generation for Treatment Efficacy and Monitoring of Octocog Alpha and Emicizumab in Severe Hemophilia A – Research and Practice in Thrombosis and Haemostasis”
Title: Intrinsic Activated Thrombin Generation for Treatment Efficacy and Monitoring of Octocog Alpha and Emicizumab in Severe Hemophilia A
Authors: Emma H. Urlings, Floor C.J.I. Heubel-Moenen, René van Oerle, Dave L.S. Hellenbrand, Paola E.J. van der Meijden, Tilman M. Hackeng, Hugo ten Cate, Magdolna Nagy, Yvonne M.C. Henskens, Henri M.H. Spronk
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy